Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869414 · ClinicalTrials.gov registry record · NA
Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00869414: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT00869414 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869414, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This research is a prospective, randomized, cross-over study that is being done to compare the effect of morning only, evening only and twice daily insulin glargine (Lantus®) on hypoglycemia (blood glucose level \<70 mg/dL) as measured by continuous glucose monitoring (CGM) in patients with type 1 diabetes.
Interventions
- DRUG Evening only administration of insulin glargine
- DRUG Morning only administration of insulin glargine
- DRUG split dose insulin glargine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869414
The ClinicalTrials.gov registry entry for NCT00869414 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Evening only administration of insulin glargine is the first listed.
NCT00869414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869414 about?
NCT00869414 is a clinical study titled "Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes". This research is a prospective, randomized, cross-over study that is being done to compare the effect of morning only, evening only and twice daily insulin glargine (Lantus®) on hypoglycemia (blood glucose level \<70 mg/dL) as measured by continuous glucose monitoring (CGM) in patients with type 1 d...
What is the current status of trial NCT00869414?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2009-07. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00869414?
The interventions under investigation include: Evening only administration of insulin glargine (DRUG), Morning only administration of insulin glargine (DRUG), split dose insulin glargine (DRUG).
Who is sponsoring clinical trial NCT00869414?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.